Kobayashi Pharmaceutical Co Ltd 2017 Integrated Report
Company: Kobayashi Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2017
Type: Integrated Report
Pages: 110
The report presents FY2017 consolidated net sales of ¥156.7 billion, up 8.3%, alongside record profit attributable to owners of parent of ¥15.8 billion. The company launched 29 new products and reported 20 consecutive fiscal periods of profit growth. It highlights establishment of the Kobayashi Foundation in 2017, which selected support and award recipients for 14 projects. The report also describes FY2020 environmental targets, including a 20% reduction in manufacturing emissions per unit of sales versus fiscal 2005/3 and a 99.5% recycling-rate target.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.